Clinical Trial Update: Renal Function Evaluation After Reduction of Cyclosporine A Dose in Renal Transplant Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating renal function after reducing cyclosporine A dose in renal transplant patients; completed study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Failure
• Kidney Transplantation

Drugs mentioned

• Cyclosporine A (cyclosporine)

Snippet

Sponsor: University Hospital, Rouen | Conditions: Kidney Transplantation, Primary Prevention | Phase 3 | Status: COMPLETED